N
Nuvation Bio D
D
NUVB
1.95000
USD
0.17
(9.55%)
قبل الجلسة
حجم التداول
76
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
663,512,803
العنوان: Nuvation Bio
القطاع: Healthcare
الصناعة: Biotechnology
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.